Michael Parr is a skilled professional in the biotechnology field, holding a Ph.D. in Biochemistry and Molecular Biology from The University of British Columbia. They served as Director of Commercial Project Development at CDRD Ventures Inc. from 2008 to 2013 and later became the President and Chief Scientific Officer at Sitka Biopharma until 2021. Currently, Michael holds the position of Director of Formulation and Process Development at Evonik. They also have prior experience as Program Manager for External Partnerships at Angiotech and as Associate Director for Oncology and Gene Delivery at Biogen Idec.
This person is not in any teams
This person is not in any offices